0001104659-21-028471.txt : 20210225
0001104659-21-028471.hdr.sgml : 20210225
20210225212504
ACCESSION NUMBER: 0001104659-21-028471
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210225
FILED AS OF DATE: 20210225
DATE AS OF CHANGE: 20210225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: UKWU HENRIETTA
CENTRAL INDEX KEY: 0001840591
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40119
FILM NUMBER: 21683343
MAIL ADDRESS:
STREET 1: 2005 MARKET STREET, SUITE 2030
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IBERE PHARMACEUTICALS
CENTRAL INDEX KEY: 0001835205
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 981564986
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2005 MARKET STREET, SUITE 2030
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 267-765-3222
MAIL ADDRESS:
STREET 1: 2005 MARKET STREET, SUITE 2030
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
3
1
tm217951d4_3.xml
OWNERSHIP DOCUMENT
X0206
3
2021-02-25
0
0001835205
IBERE PHARMACEUTICALS
IBER
0001840591
UKWU HENRIETTA
C/O IBERE PHARMACEUTICALS
2005 MARKET STREET, SUITE 2030
PHILADELPHIA
PA
19103
1
0
0
0
Class B Ordinary Shares
Class A Ordinary Shares
25000
D
As described in the issuer's registration statement on Form S-1 (File No. 333-252863) (the "Registration Statement") under the heading "Description of Securities--Founder Shares," the shares of Class B ordinary shares, par value $0.0001 per share, will automatically be converted into shares of Class A ordinary shares, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis subject to adjustment pursuant to certain anti-dilution rights described therein.
/s/ Henrietta Ukwu
2021-02-25